AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Brain Hemorrhages Article
PDF (1.5 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Open Access

Intracerebral hemorrhage in translational research

Ruiyi Zhanga, Qian Baia, Yang Liua, Yan Zhanga, Zhaofu Shenga, Mengzhou Xuea( ), V. Wee Yongb( )
The Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Henan Joint International Laboratory of Intracerebral Hemorrhagic Brain Injury and Henan Medical Key Laboratory of Translational Cerebrovascular Diseases, Zhengzhou, Henan, China
Hotchkiss Brain Institute and Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
Show Author Information

Abstract

Intracerebral hemorrhage (ICH) is a serious stroke subtype with high morbidity and mortality. The prognosis of ICH is poor. In recent years, there have been many studies on how to improve the prognosis of ICH. This article mainly summarizes the research progress of ICH in translational research, including its risk factors and pathogenesis, course of disease, primary and secondary ICH brain injury, its prevention and treatment strategies.

Keywords

Intracerebral hemorrhageBrain injuryNeuroinflammationNeuroimmunologyNeuronal death

References

1

Kang D-W. Intracerebral hemorrhage: large disease burden but less therapeutic progress. J Stroke. 2017;19:1-2.
Crossref Google Scholar
2

Sessa M. Intracerebral hemorrhage and hypertension. Neurol Sci. 2008;29:258.
Crossref Google Scholar
3

Godoy DA, Piñero GR, Koller P, Masotti L, Di Napoli M. Steps to consider in the approach and management of critically ill patient with spontaneous intracerebral hemorrhage. World J Crit Care Med. 2015;4:213.
Crossref Google Scholar
4

An SJ, Kim TJ, Yoon B-W. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke. 2017;19:3.
Crossref Google Scholar
5

Suzuki Y, Sato T, Sakuma J, et al. Intracranial hemorrhage and platelet transfusion after administration of anti-platelets agents: Fukushima Prefecture. Fukushima J Med Sci. 2016;2015–2026.
Crossref Google Scholar
6

Tormoehlen LM, Blatsioris AD, Moser EA, et al. Disparities and guideline adherence in drugs of abuse screening in intracerebral hemorrhage. Neurology. 2017;88:252-258.
Crossref Google Scholar
7

Klys M, Konopka T, Rojek S. Intracerebral hemorrhage associated with amphetamine. J Anal Toxicol. 2005;29:577-581.
Crossref Google Scholar
8

Kim JK, Shin JJ, Park SK, Hwang YS, Kim TH, Shin HS. Prognostic factors and clinical outcomes of acute intracerebral hemorrhage in patients with chronic kidney disease. J Korean Neurosurg Soc. 2013;54:296.
Crossref Google Scholar
9

Brouwers HB, Greenberg SM. Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis. 2013;35:195-201.
Crossref Google Scholar
10

Xi G, Strahle J, Hua Y, Keep RF. Progress in translational research on intracerebral hemorrhage: is there an end in sight?. Prog Neurobiol. 2014;115:45-63.
Crossref Google Scholar
11

Wada R, Aviv RI, Fox AJ, et al. CT angiography ‘‘spot sign” predicts hematomaexpansion in acute intracerebral hemorrhage. Stroke. 2007;38:1257-1262.
Crossref Google Scholar
12

Bates T, Phatourous C, Van Heerden J. Spot sign, prognosis and intracerebral haemorrhage. QJM. 2017;110:51-52.
Crossref Google Scholar
13

Chen S, Zeng L, Hu Z. Progressing haemorrhagic stroke: categories, causes, mechanisms and managements. J Neurol. 2014;261:2061-2078.
Crossref Google Scholar
14

Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11:720-731.
Crossref Google Scholar
15

Vespa P, Hanley D, Betz J, et al. ICES (intraoperative stereotactic computed tomography-guided endoscopic surgery) for brain hemorrhage: a multicenter randomized controlled trial. Stroke. 2016;47:2749-2755.
Crossref Google Scholar
16

Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355-2365.
Crossref Google Scholar
17

Qureshi AI, Palesch YY, Barsan WG, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375:1033-1043.
Crossref Google Scholar
18

Diringer MN, Skolnick BE, Mayer SA, et al. Thromboembolic events with recombinant activated factor Ⅶ in spontaneous intracerebral hemorrhage: results from the factor seven for acute hemorrhagic stroke (FAST) trial. Stroke. 2010;41:48-53.
Crossref Google Scholar
19
Kawai N, Nakamura T, Early Nagao S. hemostatic therapy using recombinant factor VIIa in a collagenase-induced intracerebral hemorrhage model in ratsBrain Edema XIII. Springer; 2006:212–217.
Crossref
20

Illanes S, Zhou W, Schwarting S, Heiland S, Veltkamp R. Comparative effectiveness of hemostatic therapy in experimental warfarin-associated intracerebral hemorrhage. Stroke. 2011;42:191-195.
Crossref Google Scholar
21

Lattanzi S, Silvestrini M. Blood pressure in acute intra-cerebral hemorrhage. Ann Transl Med. 2016;4.
Crossref Google Scholar
22

Bai Q, Xue M, Yong VW. Microglia and macrophage phenotypes in intracerebral haemorrhage injury: therapeutic opportunities. Brain. 2020. https://doi.org/10.1093/brain/awz393 , pii: awz393 [Epub ahead of print].
Crossref Google Scholar
23

Xue M, Del Bigio MR. Injections of blood, thrombin, and plasminogen more severely damage neonatal mouse brain than mature mouse brain. Brain Pathol. 2005;15:273-280.
Crossref Google Scholar
24

Xue M, Balasubramaniam J, Parsons KA, McIntyre IW, Peeling J, Del Bigio MR. Does thrombin play a role in the pathogenesis of brain damage after periventricular hemorrhage?. Brain Pathol. 2005;15:241-249.
Crossref Google Scholar
25

Xue M, Hollenberg MD, Demchuk A, Yong VW. Relative importance of proteinase-activated receptor-1 versus matrix metalloproteinases in intracerebral hemorrhage-mediated neurotoxicity in mice. Stroke. 2009;40:2199-2204.
Crossref Google Scholar
26

Xue M, Del Bigio MR. Acute tissue damage after injections of thrombin and plasmin into rat striatum. Stroke. 2001;32:2164-2169.
Crossref Google Scholar
27

Xue M, Hollenberg MD, Yong VW. Combination of thrombin and matrix metalloproteinase-9 exacerbates neurotoxicity in cell culture and intracerebral hemorrhage in mice. J Neurosci. 2006;26:10281-10291.
Crossref Google Scholar
28

Babu R, Bagley JH, Di C, Friedman AH, Adamson C. Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage–induced secondary brain injury and as potential targets for intervention. Neurosurg Focus. 2012;32:E8.
Crossref Google Scholar
29

Xue M, Fan Y, Liu S, Zygun DA, Demchuk A, Yong VW. Contributions of multiple proteases to neurotoxicity in a mouse model of intracerebral haemorrhage. Brain. 2009;132(Pt 1):26-36.
Crossref Google Scholar
30

Aronowski J, Zhao X. Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke. 2011;42:1781-1786.
Crossref Google Scholar
31

Xue M, Mikliaeva EI, Casha S, Zygun D, Demchuk A, Yong VW. Improving outcomes of neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in mice. Am J Pathol. 2010;176:1193-1202.
Crossref Google Scholar
32

Wang G, Li Z, Li S, et al. Minocycline preserves the integrity and permeability of BBB by altering the activity of DKK1-Wnt signaling in ICH model. Neuroscience. 2019;415:135-146.
Crossref Google Scholar
33

Sheng Z, Liu Y, Li H, et al. Efficacy of minocycline in acute ischemic stroke: a systematic review and meta-analysis of rodent and clinical studies. Front Neurol. 2018;9:1103.
Crossref Google Scholar
34

Fouda AY, Newsome AS, Spellicy S, et al. Minocycline in acute cerebral hemorrhage: an early phase randomized trial. Stroke. 2017;48:2885-2887.
Crossref Google Scholar
35

Yong HYF, Rawji KS, Ghorbani S, Xue M, Yong VW. The benefits of neuroinflammation for the repair of the injured central nervous system. Cell Mol Immunol. 2019;16:540-546.
Crossref Google Scholar
36

Dang B, Duan X, Wang Z, He W, Chen G. A therapeutic target of cerebral hemorrhagic stroke: matrix metalloproteinase-9. Curr Drug Targets. 2017;18:1358-1366.
Crossref Google Scholar
37

Chang JJ, Emanuel BA, Mack WJ, Tsivgoulis G, Alexandrov AV. Matrix metalloproteinase-9: dual role and temporal profile in intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2014;23:2498-2505.
Crossref Google Scholar
38

Xue M, Yong VW. Matrix metalloproteinases in intracerebral hemorrhage. Neurol Res. 2008;30:775-782.
Crossref Google Scholar
39

Wang J, Dore S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab. 2007;27:894-908.
Crossref Google Scholar
40

Zhou Y, Wang Y, Wang J, Anne Stetler R, Yang QW. Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol. 2014;115:25-44.
Crossref Google Scholar
41

Garrett MC, Otten ML, Starke RM, et al. Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage. Brain Res. 2009;1298:171-177.
Crossref Google Scholar
42

Ducruet AF, Zacharia BE, Hickman ZL, et al. The complement cascade as a therapeutic target in intracerebral hemorrhage. Exp Neurol. 2009;219:398-403.
Crossref Google Scholar
43

Sun YM, Wang YT, Jiang L, Xue MZ. The effects of deferoxamine on inhibition for microglia activation and protection of secondary nerve injury after intracerebral hemorrhage in rats. Pak J Pharm Sci. 2016;29(3 Suppl):1087-1093.
Google Scholar
44

Hatakeyama T, Okauchi M, Hua Y, Keep RF, Xi G. Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats. Transl Stroke Res. 2013;4:546-553.
Crossref Google Scholar
45

Xie Q, Gu Y, Hua Y, Liu W, Keep RF, Xi G. Deferoxamine attenuates white matter injury in a piglet intracerebral hemorrhage model. Stroke. 2014;45:290-292.
Crossref Google Scholar
46

Yeatts SD, Palesch YY, Moy CS, Selim M. High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods. Neurocrit Care. 2013;19:257-266.
Crossref Google Scholar
47

LeBlanc 3rd RH, Chen R, Selim MH, Hanafy KA. Heme oxygenase-1-mediated neuroprotection in subarachnoid hemorrhage via intracerebroventricular deferoxamine. J Neuroinflammation. 2016;13:244.
Crossref Google Scholar
48

Lyden PD, Shuaib A, Lees KR, et al. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT trial. Stroke. 2007;38:2262-2269.
Crossref Google Scholar
49

Righy C, Bozza MT, Oliveira MF, Bozza FA. Molecular, cellular and clinical aspects of intracerebral hemorrhage: are the enemies within?. Curr Neuropharmacol. 2016;14:392-402.
Crossref Google Scholar
50

Guo F, Hua Y, Wang J, Keep RF, Xi G. Inhibition of carbonic anhydrase reduces brain injury after intracerebral hemorrhage. Transl Stroke Res. 2012;3:130-137.
Crossref Google Scholar
51

Sharp F, Liu DZ, Zhan X, Ander BP. Intracerebral hemorrhage injury mechanisms: glutamate neurotoxicity, thrombin, and Src. Acta Neurochirurgica Suppl. 2008;105:43-46.
Crossref Google Scholar
52

Bullock MR, Merchant RE, Carmack CA, et al. An open-label study of CP-101,606 in subjects with a severe traumatic head injury or spontaneous intracerebral hemorrhage. Ann NY Acad Sci. 1999;890:51-58.
Crossref Google Scholar
53

Chen TY, Lin CL, Wang LF, Tsai KL, Lin JY, Hsu C. Targeting GPER1 to suppress autophagy as a male-specific therapeutic strategy for iron-induced striatal injury. Sci Rep. 2019;9:6661.
Crossref Google Scholar
54

Durocher M, Ander BP, Jickling G, et al. Inflammatory, regulatory, and autophagy co-expression modules and hub genes underlie the peripheral immune response to human intracerebral hemorrhage. J Neuroinflammation. 2019;16:56.
Crossref Google Scholar
55

Li Q, Weiland A, Chen X, et al. Ultrastructural characteristics of neuronal death and white matter injury in mouse brain tissues after intracerebral hemorrhage: coexistence of ferroptosis, autophagy, and necrosis. Front Neurol. 2018;9:581.
Crossref Google Scholar
56

Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450-1460.
Crossref Google Scholar
57

Sinar E, Mendelow AD, Graham DI, Teasdale GM. Experimental intracerebral hemorrhage: effects of a temporary mass lesion. J Neurosurg. 1987;66:568-576.
Crossref Google Scholar
58

Xue M, Del Bigio MR. Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death. Neurosci Lett. 2000;283:230-232.
Crossref Google Scholar
59

Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M. Collagenase-induced intracerebral hemorrhage in rats. Stroke. 1990;21:801-807.
Crossref Google Scholar
60

Liard J-F, Cowley Jr AW, McCaa RE, McCaa CS, Guyton AC. Renin, aldosterone, body fluid volumes, and the baroreceptor reflex in the development and reversal of Goldblatt hypertension in conscious dogs. Circ Res. 1974;34:549-560.
Crossref Google Scholar
61

Goddard J, Lewis RM, Armstrong DL, Zeller RS. Moderate, rapidly induced hypertension as a cause of intraventricular hemorrhage in the newborn beagle model. J Pediatr. 1980;96(6):1057-1060.
Crossref Google Scholar
62

Xi G, Wagner KR, Keep RF, et al. Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke. 1998;29:2580-2585.
Crossref Google Scholar
63

Rosenberg GA, Estrada E, Kelley RO, Kornfeld M. Bacterial collagenase disrupts extracellular matrix and opens blood-brain barrier in rat. Neurosci Lett. 1993;160:117-119.
Crossref Google Scholar
64

Xue M, Del Bigio MR. Comparison of brain cell death and inflammatory reaction in three models of intracerebral hemorrhage in adult rats. J Stroke Cerebrovasc Dis. 2003;12(3):152-159.
Crossref Google Scholar
65

Poon CC, Sarkar S, Yong VW, Kelly JJ. Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis. Brain. 2017;140:1548-1560.
Crossref Google Scholar
66

Wan S, Cheng Y, Jin H, et al. Microglia activation and polarization after intracerebral hemorrhage in mice: the role of protease-activated receptor-1. Transl Stroke Res. 2016;7:478-487.
Crossref Google Scholar
67

Kobayashi K, Imagama S, Ohgomori T, et al. Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis. 2013;4. e525–e525.
Crossref Google Scholar
68

Yang X, Sun J, Kim TJ, et al. Pretreatment with low-dose fimasartan ameliorates NLRP3 inflammasome-mediated neuroinflammation and brain injury after intracerebral hemorrhage. Exp Neurol. 2018;310:22-32.
Crossref Google Scholar
69

Lan X, Han X, Li Q, et al. Pinocembrin protects hemorrhagic brain primarily by inhibiting toll-like receptor 4 and reducing M1 phenotype microglia. Brain Behav Immun. 2017;61:326-339.
Crossref Google Scholar
70

Yang Z, Dong S, Zheng Q, et al. FTY720 attenuates iron deposition and glialresponses in improving delayed lesion and long-term outcomes of collagenase-induced intracerebral hemorrhage. Brain Res. 2019;1718:91-102.
Crossref Google Scholar
71

Sinn D-I, Lee S-T, Chu K, et al. Proteasomal inhibition in intracerebral hemorrhage: neuroprotective and anti-inflammatory effects of bortezomib. Neurosci Res. 2007;58:12-18.
Crossref Google Scholar
72

Sun N, Shen Y, Han W, et al. Selective sphingosine-1-phosphate receptor 1 modulation attenuates experimental intracerebral hemorrhage. Stroke. 2016;47:1899-1906.
Crossref Google Scholar
73

Wang Y, Chen Q, Tan Q, et al. Simvastatin accelerates hematoma resolution after intracerebral hemorrhage in a PPARγ-dependent manner. Neuropharmacology. 2018;128:244-254.
Crossref Google Scholar
74

Chang C-F, Wan J, Li Q, Renfroe SC, Heller NM, Wang J. Alternative activation-skewed microglia/macrophages promote hematoma resolution in experimental intracerebral hemorrhage. Neurobiol Dis. 2017;103:54-69.
Crossref Google Scholar
75

Lu Q, Gao L, Huang L, et al. Inhibition of mammalian target of rapamycin improves neurobehavioral deficit and modulates immune response after intracerebral hemorrhage in rat. J Neuroinflamm. 2014;11:44.
Crossref Google Scholar
76

Shi H, Zheng K, Su Z, et al. Sinomenine enhances microglia M2 polarization and attenuates inflammatory injury in intracerebral hemorrhage. J Neuroimmunol. 2016;299:28-34.
Crossref Google Scholar
77

Jiang YB, Wei KY, Zhang XY, Feng H, Hu R. White matter repair and treatment strategy after intracerebral hemorrhage. CNS Neurosci Ther. 2019;25:1113-1125.
Crossref Google Scholar
78

Shao A, Zhu Z, Li L, Zhang S, Zhang J. Emerging therapeutic targets associated with the immune system in patients with intracerebral haemorrhage (ICH): from mechanisms to translation. EBioMedicine. 2019;45:615-623.
Crossref Google Scholar
Brain Hemorrhages
Volume 1 Issue 1,
March 2020
Pages 13-18
DOI: 10.1016/j.hest.2020.02.003
Cite this article:
Zhang R, Bai Q, Liu Y, et al. Intracerebral hemorrhage in translational research. Brain Hemorrhages, 2020, 1(1): 13-18. https://doi.org/10.1016/j.hest.2020.02.003

56

Views

0

Downloads

8

Crossref

8

Web of Science

8

Scopus

Altmetrics
Received: 25 December 2019
Revised: 10 February 2020
Accepted: 11 February 2020
Published: 28 February 2020
© 2020

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Return